filmov
tv
Dr. Efstathiou Discusses ASCO GU 2022
Показать описание
ASCOcancer
cancer
cancer care
health care
oncology
american society of clinical oncology
Рекомендации по теме
0:01:14
Dr. Efstathiou Discusses ASCO GU 2022
0:02:44
Eleni Efstathiou, MD, PhD, regarding the PROSPER clinical trial from ASCO GU 2021
0:29:57
2022 ASCO GU Cancers Symposium Keynote | A Path Forward: Addressing Disparities in GU Cancers
0:02:18
Eleni Efstathiou, MD, PhD, discusses the prostate-specific membrane antigen (PSMA) lutetium
0:10:25
ASCO GU 2022 - Janssen Highlights Niraparib Combo Data
0:10:32
Latest advances in mHSPC from ASCO GU 2020
0:02:03
Eleni Efstathiou, MD, PhD, on whether genetic mutation data impacts the treatment of prostate cancer
0:02:58
Eleni Efstathiou, MD, PhD, offers opinion on the ACIS clinical trial
0:11:57
ASCO GU 21 Jason Efstathiou e José Mauricio Mota TV Onconews 100221
0:02:02
Eleni Efstathiou, MD, PhD, discusses the CheckMate 9ER clinical trial presented at ESMO 2020
0:18:13
ASCO 2021: Precision and molecular reporting for prostate cancer
0:01:00
Eleni Efstathiou, MD, PhD, offers a message for patients on clinical progress in prostate cancer
0:12:24
GU ASCO Symposium 2022 Summary
0:15:46
Updates in metastatic prostate cancer
0:01:25
Dr. Vokes Discusses 2022 ASCO Annual Meeting
0:01:33
Eleni Efstathiou, MD, PhD, offers opinion on whether CheckMate 9ER is practice-changing
1:28:41
AnCan presentation by Dr. Eleni Efstathiou - 12/19/2022
0:02:30
Panel Discussion ASCO GU 22 - bit spicy
0:00:28
ASCO GU 2022
0:01:18
Making advances in prostate cancer
0:04:35
Highlights from ASCO GU 2022
0:02:16
Expert comment: The STAMPEDE study | Eleni Efstathiou
0:33:27
Promise of personalised medicine for patients with prostate cancer
0:02:27
Eleni Efstathiou, MD, PhD, considers the role of precision medicine in prostate cancer
0:01:14
0:02:44
0:29:57
0:02:18
0:10:25
0:10:32
0:02:03
0:02:58
0:11:57
0:02:02
0:18:13
0:01:00
0:12:24
0:15:46
0:01:25
0:01:33
1:28:41
0:02:30
0:00:28
0:01:18
0:04:35
0:02:16
0:33:27
0:02:27